Robert van Nostrand

Robert van Nostrand

Fortune : 306 299 $ au 31/05/2026

69 ans
Health Technology
Commercial Services
Process Industries

Profil

Mr. Robert L.
van Nostrand
, CPA, is an Independent Director at SELLAS Life Sciences Group, Inc., an Independent Chairman at Yield10 Bioscience, Inc., a Member at Association of Biofinance Officers and a Treasurer & Director at New York Biotechnology Association, Inc. He is on the Board of Directors at Sellas Life Sciences Group Ltd., SELLAS Life Sciences Group, Inc., ITI, Inc. (New York), Brany LLC, LikeMinds, Inc. (Massachusetts) and New York Biotechnology Association, Inc. Mr. van Nostrand was previously employed as an Independent Director by Enumeral Biomedical Holdings, Inc., a Lead Independent Director by Intra-Cellular Therapies, Inc., a Chief Financial Officer & Executive Vice President by Aureon Laboratories, Inc., a Chief Financial Officer & Executive Vice President by Applied Genetics, Inc. Dermatics, an Independent Director by Achillion Pharmaceuticals, Inc., a Chief Compliance Officer & Senior Vice President by OSI Pharmaceuticals, Inc., a Chief Financial Officer & Executive VP by Applied Genetics, Inc. Dermatics, a Chief Financial Officer & Executive Vice President by Aureon Laboratories, Inc., a Chairman by Farmingdale College Foundation, and a Manager by Touche Ross & Co. He also served on the board at SELLAS Life Sciences Group, Inc. /Old/, Apex Bioventures Acquisition Corp., Apex Bioventures LLC, Achillion Pharmaceuticals, Inc. and Enumeral Biomedical Corp.
He received his undergraduate degree from Long Island University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/04/2026 32 900 ( 0,02% ) 306 299 $ 31/05/2026

Postes actifs de Robert van Nostrand

SociétésPosteDébut
YIELD10 BIOSCIENCE, INC. Président 08/11/2011
SELLAS LIFE SCIENCES GROUP, INC. Directeur/Membre du Conseil 29/12/2017
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 29/12/2017
ITI, Inc. (New York)
Directeur/Membre du Conseil 01/01/2014
Directeur/Membre du Conseil 01/01/2011
Association of Biofinance Officers
Corporate Officer/Principal -
Directeur/Membre du Conseil 20/07/2012

Anciens postes connus de Robert van Nostrand

SociétésPosteFin
INTRA-CELLULAR THERAPIES, INC. Directeur/Membre du Conseil 02/04/2025
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Robert van Nostrand

Formation de Robert van Nostrand

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

52

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Touche Ross & Co.

Commercial Services

Commercial Services

Association of Biofinance Officers

Apex Bioventures LLC

Commercial Services

Commercial Services

Health Technology

ITI, Inc. (New York)

Health Technology

Health Technology

Health Technology

Commercial Services

Aureon Laboratories, Inc.

  1. Bourse
  2. Insiders
  3. Robert van Nostrand
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT